MFDS — authorised 20 December 2002
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇰🇷 Extraneal in South Korea
MFDS authorised Extraneal on 20 December 2002
Marketing authorisation
Extraneal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Extraneal approved in South Korea?
Yes. MFDS authorised it on 20 December 2002.
Who is the marketing authorisation holder for Extraneal in South Korea?
BAXTER HLTHCARE holds the South Korean marketing authorisation.